4.6 Article

Comparison of Three Methods for LDLC Calculation for Cardiovascular Disease Risk Categorisation in Three Distinct Patient Populations

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medical Laboratory Technology

Validating the NIH LDL-C equation in a specialized lipid cohort: Does it add up?

Victoria Higgins et al.

Summary: The study validated the superiority of the NIH LDL-C equation over the Friedewald equation, particularly in patients with hypertriglyceridemia and/or low LDL-C. The NIH equation showed a stronger correlation with ultracentrifugation LDL-C and improved accuracy after applying restriction criteria, making it a more reliable choice for lipid management in clinical practice.

CLINICAL BIOCHEMISTRY (2022)

Article Biochemistry & Molecular Biology

LDL-C calculated by Friedewald, Martin-Hopkins, or NIH equation 2 versus beta-quantification: pooled alirocumab trials

Henry N. Ginsberg et al.

Summary: Accurate assessment of LDL-C levels is important for treatment recommendations. There are limitations to calculating LDL-C using the Friedewald equation, but the Friedewald, Martin-Hopkins, and NIH equation 2 methods can guide treatment decisions for most patients.

JOURNAL OF LIPID RESEARCH (2022)

Article Cardiac & Cardiovascular Systems

Discordance Between Standard Equations for Determination of LDL Cholesterol in Patients With Atherosclerosis

Aparna Sajja et al.

Summary: This study assessed the discordance of estimated LDL-C using the Friedewald, Sampson, and Martin/Hopkins equations. The results demonstrated clinically meaningful differences among equations, particularly at higher TG levels and lower LDL-C levels.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Letter Medicine, General & Internal

Is the 2020 Sampson equation the best formula for LDL-C estimation?

Federica Piani et al.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2021)

Article Medicine, General & Internal

Usefulness of novel Martin/Hopkins and Sampson equations over Friedewald equation in cardiology outpatients: A CVSCORE-TR substudy

Lale Dinc Asarcikli et al.

Summary: The study showed that in most cardiology outpatients, the Friedewald equation has excellent agreement with the novel Martin/Hopkins and Sampson equations, and treatment decisions should not change in most patients.

INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2021)

Article Cardiac & Cardiovascular Systems

Society Guidelines 2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults

Glen J. Pearson et al.

Summary: The 2021 guidelines provide updated recommendations for patients with clinical atherosclerosis, abdominal aortic aneurysm, diabetes, chronic kidney disease, and high LDL cholesterol levels, emphasizing statin therapy. The guidelines introduce lipid/lipoprotein treatment thresholds and recommend Lipoprotein(a) measurement once in a patient's lifetime for cardiovascular risk assessment. Additionally, there are new recommendations for preventative care for women with hypertensive disorders of pregnancy. The guidelines highlight the importance of health behavior modifications as the cornerstone of cardiovascular disease prevention and aim to facilitate meaningful conversations and shared decisions between patients and care providers.

CANADIAN JOURNAL OF CARDIOLOGY (2021)

Article Biochemistry & Molecular Biology

Comparative assessment of LDL-C and VLDL-C estimation in familial combined hyperlipidemia using Sampson's, Martin' and Friedewald's equations

Arsenio Vargas-Vazquez et al.

Summary: In FCHL, the study compared the performance of three methods for estimating LDL-C and found that Sampson's formula showed higher accuracy and concordance with treatment goals than Friedewald's and Martin's equations. Sampson's formula demonstrated improved correlation and consistency in assessing LDL-C performance and treatment monitoring in FCHL.

LIPIDS IN HEALTH AND DISEASE (2021)

Article Cardiac & Cardiovascular Systems

Performance of novel low-density lipoprotein-cholesterol calculation methods in predicting clinical and subclinical atherosclerotic cardiovascular disease risk: The Multi-Ethnic Study of Atherosclerosis

Jing Cao et al.

Summary: In a multi-ethnic USA population, LDLMartin and LDLSampson did not over- or under-estimate ASCVD risk compared to LDLFriedewald in primary prevention according to AHA/ACC guidelines, while LDLFriedewald under-estimated subclinical ASCVD risk in the low-risk population. These findings support the replacement of LDLFriedewald by LDLMartin or LDLSampson for lipid screen in the general population.

ATHEROSCLEROSIS (2021)

Article Peripheral Vascular Disease

Comparison of Novel Equations for Estimating Low-Density Lipoprotein Cholesterol in Patients Undergoing Coronary Angiography

Barak Zafrir et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2020)

Editorial Material Cardiac & Cardiovascular Systems

Simplified Canadian Definition for Familial Hypercholesterolemia

Isabelle Ruel et al.

CANADIAN JOURNAL OF CARDIOLOGY (2018)

Article Peripheral Vascular Disease

Validity of a Novel Method for Estimating Low-Density Lipoprotein Cholesterol Levels in Cardiovascular Disease Patients Treated with Statins

Takeshi Sonoda et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)

Article Peripheral Vascular Disease

Validity of a Novel Method for Estimation of Low-Density Lipoprotein Cholesterol Levels in Diabetic Patients

Hideto Chaen et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2016)

Article Medical Laboratory Technology

Validation of a Proposed Novel Equation for Estimating LDL Cholesterol

Jeffrey W. Meeusen et al.

CLINICAL CHEMISTRY (2014)

Article Medicine, General & Internal

Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile

Seth S. Martin et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)